Cargando…
Pre-diagnostic statin use, lymph node status and mortality in women with stages I–III breast cancer
BACKGROUND: Recent meta-analyses suggest that pre-diagnostic statin use is associated with reduced breast cancer-specific mortality. Studies have shown that high breast tumour expression of the statin target (3-hydroxy-3-methylglutaryl coenzyme-A reductase) is associated with lymph-node negative can...
Autores principales: | Smith, Amelia, Murphy, Laura, Zgaga, Lina, Barron, Thomas I, Bennett, Kathleen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5558692/ https://www.ncbi.nlm.nih.gov/pubmed/28720842 http://dx.doi.org/10.1038/bjc.2017.227 |
Ejemplares similares
-
De novo post-diagnosis statin use, breast cancer-specific and overall mortality in women with stage I–III breast cancer
por: Smith, Amelia, et al.
Publicado: (2016) -
Associations between obesity, smoking and lymph node status at breast cancer diagnosis in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
por: Smith, Amelia, et al.
Publicado: (2018) -
Post-diagnostic statin use and breast cancer-specific mortality: a population-based cohort study
por: Scott, Oliver William, et al.
Publicado: (2023) -
Five-year standardised mortality ratios in a cohort of homeless people in Dublin
por: Ivers, Jo-Hanna, et al.
Publicado: (2019) -
Fat-enlarged axillary lymph nodes are associated with node-positive breast cancer in obese patients
por: diFlorio-Alexander, Roberta M., et al.
Publicado: (2021)